Drug Trial Radar · NCT01794143
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,850
Actual
Start
May 2013
Primary completion
Apr 30, 2021
Study completion Apr 30, 2021
Sponsor
- Lead sponsor
- GRADE Study GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); Centers for Disease Control and Prevention
- First posted
- Feb 18, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and patient-centered outcomes.
Conditions
- Type 2 Diabetes
- Comparative Effectiveness of Glycemia-lowering Medications
Interventions
Sulfonylurea (glimepiride)Drug
Used in accordance with labeling and/or usual practice.
DPP-4 inhibitor (sitagliptin)Drug
Used in accordance with labeling and/or usual practice
GLP-1 receptor agonist (liraglutide)Drug
Used in accordance with labeling and/or usual practice.
Insulin (glargine)Drug
Used in accordance with labeling and/or usual practice.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to HbA1c>=7%, While Receiving Metformin and the Randomly Assigned Glucose-lowering Study MedicationTime frame: Quarterly for 4 to 7 years
- HbA1c>=7%, While Receiving Metformin and the Randomly Assigned Glucose-lowering Study MedicationTime frame: Quarterly, 4-7 years
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama-Birmingham
Birmingham, Alabama
Southwestern American Indian Center
Phoenix, Arizona
Veterans Medical Research Foundation, San Diego (San Diego VA)
San Diego, California
University of Colorado
Denver, Colorado
Yale University School of Medicine
New Haven, Connecticut
South Florida VA Foundation (Miami VA)
Miami, Florida
Atlanta VA Medical Center
Decatur, Georgia
Kaiser Permanente of Georgia
Duluth, Georgia
Pacific Health Research and Education Institute (VA Pacific Islands)
Honolulu, Hawaii
Indiana University School of Medicine
Indianapolis, Indiana
University of Iowa
Iowa City, Iowa
Pennington Biomedical Research Center
Baton Rouge, Louisiana
MedStar Health Research Institute
Hyattsville, Maryland
Massachusetts General Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
International Diabetes Center
Minneapolis, Minnesota
University of Minnesota
Minneapolis, Minnesota
Washington University School of Medicine
St Louis, Missouri
University of Nebraska
Omaha, Nebraska
University of New Mexico School of Medicine
Albuquerque, New Mexico
State University of New York (SUNY)-Downstate Medical Center
Brooklyn, New York
Columbia University Naomi Berrie Diabetes Center
New York, New York
Mount Sinai St. Luke's Hospital
New York, New York
Albert Einstein College of Medicine
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
University of North Carolina Diabetes Care Center
Durham, North Carolina
University of Cincinnati
Cincinnati, Ohio
Case Western Reserve University School of Medicine
Cleveland, Ohio
Kaiser Permanente Northwest
Portland, Oregon
Oregon Health and Science University
Portland, Oregon
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor Endocrine Center
Dallas, Texas
University of Texas-Southwestern Medical Center
Dallas, Texas
Baylor College of Medicine
Houston, Texas
University of Texas Health Science Center
San Antonio, Texas
Seattle Institute for Biomedical and Clinical Research
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.